Introduction: Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, has been known to inhibit the expression of RANKL on osteoblasts to inhibit osteoclastogenesis. In the model of bisphosphonate-related osteonecrosis of the jaw, administration of ZA suppressed Treg-cell activity and activated inflammatory Th17 cells. Our previous studies also demonstrated that ZA modulate immunity by inhibiting the expansion, migration, immunosuppressive function and prometastatic ability of Tregs in vitro. In this study, we further confirmed the effects of ZA on the breast tumor cells in vivo. Methods: We inoculated mouse 4T1 breast cancer cells (1 x 106) into the back of BALB/c mice (n = 30), and treated with ZA 100 ug/kg five times every 3 days. The absolute counts and relative ratio of Treg cells (CD4+CD25+) and activated cytotoxic T lymphocytes (CD8+) infiltration in the tumoral area of breast tumor tissue of mice were analyzed.
Introduction: Chromosomal translocations involving the erythroblast transformation-specific (ETS) transcription factors, such as ERG and ETV1, are frequent events in human prostate cancer pathogenesis. In particular, the TMPRSS2-ERG fusion gene has recently been found to be the most frequent gene rearrangement in prostate cancers. Previously, IHC stain and FISH assay have been used to detect ERG translocation. However, these methods do not provide detailed information, such as the exact breakpoint and partner gene. Here, we want to test the feasibility of detection of ERG translocation by targeted RNA-seq. Methods and Materials: Tissue microarray (TMA) was constructed from 27 cases of prostatic adenocarcinoma. TMA slides were subjected to ERG immunostaining. Cases with positive ERG staining were identified. For targeted RNA-seq, we used Archer FusionPlex (ArcherDX, Boulder, CO) Solid Tumor Kit, which uses Anchored Multiplex PCR-based enrichment method and can detect fusions associated with >50 genes. Both ERG-positive and -negative tissue was subject for this assay. Results: Eight samples (four of ERG+ prostate cancer and four of ERG-tissue) generated a total of two GB sequencing data. ERG translocation was not found in any of the four samples of ERG-tissue. TMPRSS2-ERG fusion was identified in one of the samples of ERG+ prostate cancer. Conclusions: Our preliminary test demonstrated that it is feasible to detect ERG rearrangement in formalin-fixed paraffin-embedded tissue by targeted RNA-seq, which could provide much more detailed information than other traditional methods. However, this test is still very challenging and requires strong bioinformatics support.
Evaluation and Validation of an Automated Platform for Ribonucleic Acid Extraction From Formalin-Fixed Paraffin-Embedded Tissue
Hung Tran, Danielle Pancirer, Gloria Cheang, Yuewei Li, PhD, Elyze Merzier, Jeff Catalano; Weill Cornell Medicine, New York, NY Isolation of high quality ribonucleic acid (RNA) from formalin-fixed paraffin-embedded (FFPE) archival material is often a challenging task due to RNA degradation, which occurs during the formalin fixation process. Presently over 80% of tissue tested in molecular diagnostics laboratories are derived from FFPE samples. Thus, utilizing a robust and reliable RNA extraction protocol is an immensely critical tool for many clinical lab applications. An array of commercially available manual and automated extraction kits on the market promise high-quality RNA yields. Currently our laboratory employs a manual extraction protocol. However, as our
